Editorial

Editorial

• Talha Müezzinoglu

Review

Nomograms for prostate cancer: which and when to use

• Saadettin Eskiçorapçı
• Deniz Bolat

What is the best cutoff value of PSA in detection of prostate cancer

• Hakan Gemalmaz

NON-PSA biomarkers for prostate cancer

• Yarkın Kamil Yakupoğlu
• Yakup Bostancı
• Ender Özden

Repeat prostate biopsy: who, when, how?

• Hayrettin Şahin

Current status of pain control in trus-guided prostate biopsy

• İlker Seçkiner
• Ömer Bayrak

Active surveillance for localized prostate cancer

• İlker Tınay
• Levent Türkeri

Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy

• Ali Cansu Bozacı
• Bülent Akdoğan
• Haluk Özen

Current surgical approaches in local invasive prostate cancer: urologist approach

• Zafer Kozacıoğlu
• Bülent Günlüsoy

Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective

• Ömür Karakoyun Çelik

Management of recurrences after radiation therapy used for curative intent in prostate cancer

• Yılören Tanıdır
• Levent Türkeri

Management of infravesical strictures after radical retropubic prostatectomy

• Mustafa Karalar
• İbrahim Keleş
• Mutlu Ateş

Laparo-Endoscopic Single Site (LESS) radical prostatectomy: does port number decrease?

• Bircan Mutlu
• Volkan Tuğcu

Prostate cancer in the era of robotic surgery

• Çag Çal

Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T

• Güven Aslan

New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100

• Sıtkı Ün
• Ferruh Zorlu

Update in the management of skeletal related events for metastatic prostate cancer: Denosumab, Alfaradin

• Serdar Çelik
• Uğur Mungan

The significance of tertiary Gleason pattern in prostate cancer

• H. Hüseyin Tavukçu
• Polat Türker

Nursing interventions in patients receiving Taxan Chemotherapy

• Yeter Kırdal

Article - Comment

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

• Ali F. Şahin